Metastatic prostate cancer is cancer that began in the prostate but has spread to other parts of the body. There's no cure, but there are a number of effective treatments you can discuss with a ...
An AI-powered biomarker based on histology alone predicted survival among men with metastatic hormone-sensitive prostate cancer and identified those who benefitted from escalation to triplet therapy.
A new form of immunotherapy using innovative nanoparticles can delay resistance to hormone therapy and help men with prostate cancer live longer. Researchers from the University of Sheffield have ...
ThyBlackMan on MSNOpinion
Black men, the prostate cancer screening conversation should begin at 40
Black men face earlier and higher prostate cancer risk. Learn why the PSA screening conversation should begin between ages 40 ...
Phase I Trial of Intravesical Gemcitabine in Bacillus Calmette-Guérin–Refractory Transitional-Cell Carcinoma of the Bladder PURPOSE: To assess whether failure to maintain local control (LC) of ...
In prostate cancer, hormone therapy is treatment to keep the cancer cells from getting testosterone, the main male hormone (androgen). Hormone therapy for prostate cancer is also called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results